Meningitis B vaccine

Meningococcal B (MenB or Bexsero)) vaccine is routinely given to babies in the UK at 2, 4 and 12 months.

The vaccine was introduced to the UK schedule in September 2015.

The MenB vaccine has been shown to be working well following its introduction to UK infants, with cases of MenB halving in vaccine eligible age groups ten months after the vaccine was introduced.

MenB vaccines can be purchased privately, so people who are not currently eligible on the NHS can get vaccinated if they pay for it and we are offering it to all age groups of children.

Meningococcal meningitis and septicaemia remain the leading infectious cause of death for children under five in the UK. Vaccines are the only way to prevent meningitis and have almost eliminated some other causes of this deadly disease. Since the first meningitis vaccine was introduced against Hib meningitis in 1992, many kinds of meningitis have been reduced or have dwindled to a mere handful of cases, including Hib, MenC and pneumococcal.

Ten months after the programme was introduced, disease surveillance revealed that cases of disease had halved in vaccine eligible age groups. Based on this data, vaccine efficacy against all MenB strain after two doses of vaccine has been calculated to be 83%